“Infliximab For The Treatment Of Active Scleritis”. Can J Ophthalmol 44. Can J Ophthalmol: e9-e12. http://www.ncbi.nlm.nih.gov/pubmed/19506593.
. 2009. “A Double-Masked, Randomized Study To Investigate The Safety And Efficacy Of Daclizumab To Treat The Ocular Complications Related To Behçet's Disease”. Ocul Immunol Inflamm 15. Ocul Immunol Inflamm: 63-70. http://www.ncbi.nlm.nih.gov/pubmed/17558830.
. 2007. “Randomized Cinical Trial Of Vitamin E In The Treatment Of Uveitis-Associated Macular Edema”. Am J Ophthalmol 141. Am J Ophthalmol: 193-194. http://www.ncbi.nlm.nih.gov/pubmed/16386999.
. 2006. “Initial Evaluation Of Subcutaneous Daclizumab Treatments For Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series”. Ophthalmology 112. Ophthalmology: 764-770. http://www.ncbi.nlm.nih.gov/pubmed/15878055.
. 2005. . 2003.
. 1999.
“Treatment Of Noninfectious Intermediate And Posterior Uveitis With The Humanized Anti-Tac Mab: A Phase I/ii Clinical Trial”. Proceedings Of The National Academy Of Science Usa 96. Proceedings Of The National Academy Of Science Usa: 7462-66.
. 1999.